Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T21:32:20.600Z.
Calculation as of: 2026-10-06T21:32:20.600Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: a63c12ce7055b0216585e16b4e08b2fd6453147ab6d4be874ec80e726ee32667
PEG RATIO
N/A
Health Catalyst, Inc.
Market Cap
$130.79M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Health Catalyst, Inc. (HCAT) | $130.79M | N/A |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | N/A |
| LifeMD, Inc. (LFMD)vs › | $132.03M | N/A |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $127.98M | N/A |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | N/A |
| Organigram Global Inc. (OGI)vs › | $136.57M | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | N/A |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | N/A |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
